CA Stock MarketDetailed Quotes

Revive Therapeutics Ltd (RVV)

Watchlist
  • 0.035
  • 0.0000.00%
15min DelayMarket Closed May 1 13:11 ET
15.25MMarket Cap-1.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revive Therapeutics Ltd (RVV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
96.29%-8.07K
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
Net income from continuing operations
34.54%-238.73K
40.37%-281.75K
-95.98%-11.01M
-271.19%-9.6M
69.17%-577.18K
52.67%-364.71K
-20.96%-472.51K
11.11%-5.62M
-116.80%-2.59M
3.71%-1.87M
Operating gains losses
-124.16%-953
247.90%1.23K
-142.31%-73.85K
-35,763.54%-64.55K
-107.12%-12.41K
394.62%3.95K
-165.33%-833
10,727.85%174.55K
113.57%181
348,956.00%174.43K
Depreciation and amortization
-22.58%48
-25.81%46
-24.39%248
-24.39%62
-24.39%62
-24.39%62
-24.39%62
-24.42%328
-24.77%82
-24.07%82
Asset impairment expenditure
----
----
300.00%9.38M
----
----
----
----
201.75%2.34M
----
----
Unrealized gains and losses of investment securities
-33.33%4.02K
--0
106.87%10.05K
-92.75%729
98.25%-2.74K
--6.03K
--6.03K
-267.18%-146.28K
-88.52%10.05K
---156.33K
Remuneration paid in stock
--0
--19.95K
-9.02%124.15K
--0
--124.15K
--0
--0
--136.45K
--0
----
Other non cashItems
--1.31K
12,258.09%68.71K
5,367.70%201.92K
557.69%201.37K
--0
--0
-34.67%556
-97.90%3.69K
-5,318.98%-44K
-96.58%5.95K
Change In working capital
65.02%226.23K
1,564.81%49.41K
424.86%602.75K
4,203.89%74.9K
419.81%394.13K
189.94%137.09K
96.85%-3.37K
75.18%-185.54K
99.24%-1.83K
119.59%75.82K
-Change in receivables
-375.14%-33.15K
-34.66%-6.26K
96.74%20.95K
-77.79%12.85K
105.08%703
137.79%12.05K
-211.52%-4.65K
-82.17%10.65K
62.92%57.85K
30.94%-13.83K
-Change in prepaid assets
-90.28%9.45K
-153.51%-32.18K
205.78%252.73K
105.25%11.52K
381.80%83.81K
453.12%97.27K
210.38%60.14K
-83,436.36%-238.91K
-1,461.17%-219.41K
9.11%17.39K
-Change in payables and accrued expense
799.85%249.93K
198.86%87.85K
576.54%289.06K
-68.37%50.53K
314.65%299.63K
120.11%27.78K
-73.79%-88.86K
105.64%42.73K
154.84%159.73K
118.87%72.26K
-Change in other working capital
----
----
--40K
--0
--10K
--0
--30K
----
----
----
Cash from discontinued investing activities
Operating cash flow
96.29%-8.07K
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
Investing cash flow
Cash flow from continuing investing activities
0
0
-30K
0
0
0
-30K
0
40K
-40K
Net investment purchase and sale
--0
--0
---30K
--0
--0
--0
---30K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
---30K
--0
--0
--0
---30K
--0
--40K
---40K
Financing cash flow
Cash flow from continuing financing activities
0
148.8K
-98.02%39.15K
35.38%-25.85K
-96.78%65K
0
0
-52.91%1.98M
-40K
-50.84%2.02M
Net issuance payments of debt
--0
--0
197.88%39.15K
35.38%-25.85K
--65K
--0
--0
---40K
---40K
--0
Net common stock issuance
--0
--148.8K
--0
--0
--0
--0
--0
-48.38%2.02M
--0
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--148.8K
-98.02%39.15K
35.38%-25.85K
-96.78%65K
--0
--0
-52.91%1.98M
---40K
-50.84%2.02M
Net cash flow
Beginning cash position
-92.33%20.95K
-98.12%14.56K
-62.96%773.07K
-95.58%46.42K
-92.18%55.42K
-82.85%273K
-62.96%773.07K
-46.69%2.09M
-60.48%1.05M
-0.25%708.42K
Current changes in cash
96.29%-8.07K
101.28%6.39K
42.29%-758.51K
88.47%-31.86K
-102.64%-8.99K
75.37%-217.58K
-0.92%-500.07K
28.11%-1.31M
51.36%-276.33K
-82.47%340.98K
End cash Position
-76.75%12.88K
-92.33%20.95K
-98.12%14.56K
-98.12%14.56K
-95.58%46.42K
-92.18%55.42K
-82.85%273K
-62.96%773.07K
-62.96%773.07K
-60.48%1.05M
Free cash from
96.29%-8.07K
69.70%-142.41K
76.67%-767.66K
97.82%-6.02K
95.48%-73.99K
75.37%-217.58K
5.14%-470.07K
45.39%-3.29M
51.36%-276.33K
24.18%-1.64M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 96.29%-8.07K69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M
Net income from continuing operations 34.54%-238.73K40.37%-281.75K-95.98%-11.01M-271.19%-9.6M69.17%-577.18K52.67%-364.71K-20.96%-472.51K11.11%-5.62M-116.80%-2.59M3.71%-1.87M
Operating gains losses -124.16%-953247.90%1.23K-142.31%-73.85K-35,763.54%-64.55K-107.12%-12.41K394.62%3.95K-165.33%-83310,727.85%174.55K113.57%181348,956.00%174.43K
Depreciation and amortization -22.58%48-25.81%46-24.39%248-24.39%62-24.39%62-24.39%62-24.39%62-24.42%328-24.77%82-24.07%82
Asset impairment expenditure --------300.00%9.38M----------------201.75%2.34M--------
Unrealized gains and losses of investment securities -33.33%4.02K--0106.87%10.05K-92.75%72998.25%-2.74K--6.03K--6.03K-267.18%-146.28K-88.52%10.05K---156.33K
Remuneration paid in stock --0--19.95K-9.02%124.15K--0--124.15K--0--0--136.45K--0----
Other non cashItems --1.31K12,258.09%68.71K5,367.70%201.92K557.69%201.37K--0--0-34.67%556-97.90%3.69K-5,318.98%-44K-96.58%5.95K
Change In working capital 65.02%226.23K1,564.81%49.41K424.86%602.75K4,203.89%74.9K419.81%394.13K189.94%137.09K96.85%-3.37K75.18%-185.54K99.24%-1.83K119.59%75.82K
-Change in receivables -375.14%-33.15K-34.66%-6.26K96.74%20.95K-77.79%12.85K105.08%703137.79%12.05K-211.52%-4.65K-82.17%10.65K62.92%57.85K30.94%-13.83K
-Change in prepaid assets -90.28%9.45K-153.51%-32.18K205.78%252.73K105.25%11.52K381.80%83.81K453.12%97.27K210.38%60.14K-83,436.36%-238.91K-1,461.17%-219.41K9.11%17.39K
-Change in payables and accrued expense 799.85%249.93K198.86%87.85K576.54%289.06K-68.37%50.53K314.65%299.63K120.11%27.78K-73.79%-88.86K105.64%42.73K154.84%159.73K118.87%72.26K
-Change in other working capital ----------40K--0--10K--0--30K------------
Cash from discontinued investing activities
Operating cash flow 96.29%-8.07K69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M
Investing cash flow
Cash flow from continuing investing activities 00-30K000-30K040K-40K
Net investment purchase and sale --0--0---30K--0--0--0---30K--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0---30K--0--0--0---30K--0--40K---40K
Financing cash flow
Cash flow from continuing financing activities 0148.8K-98.02%39.15K35.38%-25.85K-96.78%65K00-52.91%1.98M-40K-50.84%2.02M
Net issuance payments of debt --0--0197.88%39.15K35.38%-25.85K--65K--0--0---40K---40K--0
Net common stock issuance --0--148.8K--0--0--0--0--0-48.38%2.02M--0----
Proceeds from stock option exercised by employees ------------------------------0--------
Cash from discontinued financing activities
Financing cash flow --0--148.8K-98.02%39.15K35.38%-25.85K-96.78%65K--0--0-52.91%1.98M---40K-50.84%2.02M
Net cash flow
Beginning cash position -92.33%20.95K-98.12%14.56K-62.96%773.07K-95.58%46.42K-92.18%55.42K-82.85%273K-62.96%773.07K-46.69%2.09M-60.48%1.05M-0.25%708.42K
Current changes in cash 96.29%-8.07K101.28%6.39K42.29%-758.51K88.47%-31.86K-102.64%-8.99K75.37%-217.58K-0.92%-500.07K28.11%-1.31M51.36%-276.33K-82.47%340.98K
End cash Position -76.75%12.88K-92.33%20.95K-98.12%14.56K-98.12%14.56K-95.58%46.42K-92.18%55.42K-82.85%273K-62.96%773.07K-62.96%773.07K-60.48%1.05M
Free cash from 96.29%-8.07K69.70%-142.41K76.67%-767.66K97.82%-6.02K95.48%-73.99K75.37%-217.58K5.14%-470.07K45.39%-3.29M51.36%-276.33K24.18%-1.64M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -